0001104659-24-039164.txt : 20240326 0001104659-24-039164.hdr.sgml : 20240326 20240326190136 ACCESSION NUMBER: 0001104659-24-039164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240326 DATE AS OF CHANGE: 20240326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly James Patrick CENTRAL INDEX KEY: 0001506314 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 24785261 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 tm249879-4_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-03-01 0 0001000694 NOVAVAX INC NVAX 0001506314 Kelly James Patrick C/O NOVAVAX, INC. 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 0 1 0 0 EVP, CFO & Treasurer 0 Restricted Stock Units 2024-03-01 4 A 0 176000 0.00 A Common Stock 176000 176000 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date. /s/ Mark J. Casey, Attorney-in-Fact 2024-03-26